To examine the use of the aromatase inhibitor letrozole with FSH for ovarian stimulation in poor responders undergoing ovarian superovulation and IUI.
Design
Observational cohort study as a prospective clinical trial in patients with unexplained infertility and a low response to ovarian stimulation with FSH.
Setting
Two tertiary referral infertility clinics associated with the Reproductive Sciences Division, University of Toronto.
PATIENT(S): Twelve patients with unexplained infertility undergoing IUI who received FSH alone in 25 prior cycles with poor response (less than three dominant follicles).
INTERVENTION(S): Patients were offered letrozole, 2.5 mg/day from day 3-7 of the menstrual cycle with FSH (50-225 IU/day) starting on day 5-7. hCG (10,000 IU) was given when two leading follicles were >/=2 cm followed by IUI.
MAIN OUTCOME MEASURE(S): Number of mature follicles (>1.8 cm), FSH dose, endometrial thickness, and pregnancy rate.
RESULT(S): Improved response to FSH stimulation with letrozole co-treatment was evidenced by the significantly lower FSH dose associated with significantly higher number of mature follicles. During letrozole plus FSH stimulation cycles, clinical pregnancy was achieved in three cycles (21%).
CONCLUSION(S): In this preliminary report, we demonstrate a potential benefit of aromatase inhibition for improving ovarian response to FSH in poor responders.
PMID 11937133 11937133 DOI 10.1016/s0015-0282(01)03280-0 10.1016/s0015-0282(01)03280-0
Cite this article
Mitwally, M. F. M., & Casper, R. F. (2002). Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. *Fertility and sterility*, *77*(4), 776-780. https://doi.org/10.1016/s0015-0282(01)03280-0
Mitwally MFM, Casper RF. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril. 2002;77(4):776-780. doi:10.1016/s0015-0282(01)03280-0
Mitwally, M. F. M., and R. F. Casper. "Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders." *Fertility and sterility*, vol. 77, no. 4, 2002, pp. 776-780.
Practice Committee of the American Society for Reproductive Medicine2026Fertility and Sterility
Current strategies for the assessment and treatment of recurrent pregnancy loss are discussed. This replaces the previous document, titled, "Evaluation and treatment of recurrent pregnancy loss: a com...
This narrative review examines the evidence for medical optimization of inflammatory conditions, vitamin deficiencies, endocrine disorders, immune dysregulation, oligo-ovulation, and luteal phase fact...
IMPORTANCE: Restorative Reproductive Medicine (RRM) aims to restore fertility by diagnosing and treating the underlying causes of infertility. RRM is frequently promoted as an alternative to assisted ...
Objective: To examine birth outcomes between children conceived with in vitro fertilization (IVF) or intrauterine insemination (IUI) and sibling births from unassisted conceptions.
Design: Retrospect...
IVF OutcomesBirth Weight and Gestational AgeSibling Studies